The results of a late-stage trial show Menveo could offer protection against meningitis — an infection of the brain and spinal cord. Now, the drugmaker intends to file Menveo for use in infants in the U.S. and Europe.
…
It’s an important question because 5,000 potential lawsuits alleging that vaccines caused autism lurk in the background, and vaccine makers threaten to stop producing the drugs if the suits are allowed.
Continu…
Still in hot water over its “phantom recall” of a Motrin product, Johnson & Johnson looks to expand its share of the vaccine market with purchase of Dutch pharma company Crucell.
Continue reading Johnson & …